Matthias Alder
Chief Executive Officer at Gain Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Gain Therapeutics Inc., 3 years.
Gain Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Gain Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2024 | Gain Therapeutics Inc. | Option exercise | +18,750 | — | — |
| Mar 26, 2024 | Gain Therapeutics Inc. | Option exercise | +825 | — | — |
| Mar 26, 2024 | Gain Therapeutics Inc. | Option exercise | +637 | — | — |
| Mar 26, 2024 | Gain Therapeutics Inc. | Shares withheld for tax | −6,085 | $4.06 | $24,705 |
| Dec 21, 2023 | Gain Therapeutics Inc. | Open-market sale | −206 | $2.46 | $507 |
| Dec 20, 2023 | Gain Therapeutics Inc. | Option exercise | +637 | — | — |
| Dec 7, 2023 | Gain Therapeutics Inc. | Open-market sale | −1,820 | $2.50 | $4,550 |
| Oct 1, 2023 | Gain Therapeutics Inc. | Option exercise | +825 | — | — |
| Sep 20, 2023 | Gain Therapeutics Inc. | Option exercise | +2,550 | — | — |
| Jul 1, 2023 | Gain Therapeutics Inc. | Option exercise | +3,300 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.